Akthelia Pharmaceuticals
Modulating innate immunity to improve cancer therapy outcomes. .
Iceland
4 employees
Grant
Total: $64.00M
Biotechnology, Pharmaceutical
General Information
Get notified when Akthelia Pharmaceuticals moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Akthelia Pharmaceuticals
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Iceland Market
Biotechnology
About Akthelia Pharmaceuticals
Taxonomy: pharmaceuticals, antimicrobial therapeutics, drug-resistant infections, drug discovery, infectious diseases, Karolinska Institute, University of Iceland, microbial defenses, lung infections, gastrointestinal infections, antibiotic resistance, opportunistic infections, evidence-based medicine, product pipeline
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | •••••• | 1 |
|
17 Apr 2023 |
| Angel Round | •••••• | - | 01 Sep 2019 | |
| Grant | •••••• | 1 |
|
01 Mar 2013 |
| Grant | •••••• | 1 |
|
01 Mar 2012 |
| Grant | •••••• | 1 |
|
01 Mar 2010 |
Akthelia Pharmaceuticals Alternatives & Competitors
Clinical-stage biopharmaceutical company focused on novel antibiotics, antifungals, and treatments f...
...focused on discovering & developing differentiated biologic therapies for life-threatening, drug-...
Developing first-in-class solutions for unmet health and personal care needs
FAQ About Akthelia Pharmaceuticals
Don't just browse. Track.
Signal Tracker monitors Akthelia Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
